Veracyte Inc logo

VCYT - Veracyte Inc News Story

$46.91 -8.5  -15.3%

Last Trade - 04/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £2.26bn
Enterprise Value £2.01bn
Revenue £84.6m
Position in Universe 1752nd / 6647

BRIEF-Veracyte Reports Prelim Q1 2020 Financial Results

Thu 16th April, 2020 10:16pm
April 16 (Reuters) - Veracyte Inc  VCYT.O :
    * VERACYTE ANNOUNCES PRELIMINARY FIRST QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE IN RESPONSE TO COVID-19
PANDEMIC
    * SEES Q1 2020 REVENUE $30.5 MILLION TO $31.5 MILLION
    * WITHDRAWS FULL-YEAR 2020 GUIDANCE
    * Q1 GENOMIC TESTING VOLUME INCREASED APPROXIMATELY 15%
COMPARED
TO Q1 OF 2019
    * APPROXIMATELY 60 EMPLOYEES ARE BEING PUT ON A TEMPORARY
FURLOUGH
    * SECURING VENDOR DISCOUNTS AND HALTING ALL NONESSENTIAL
OUTSIDE
SPENDING
    * CHAIRMAN, CEO IS REDUCING HER BASE PAY, TARGET BONUS BY
25%
UNTIL CO CAN RESUME NORMAL OPERATIONS
    * Q1 REVENUE VIEW $30.4 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw6Cw1hWa 
Further company coverage:  VCYT.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.